UAE
QA
Mar
Egypt
Kuwait
Turkey
India
| Place of Origin: | Beijing in China |
|---|---|
| Packaging Details: | Pre-Filled Syringe (3,5,6 MIU/ml);Injection in vail (1,3,5 MIU/ml); |
Specifications
Pre-Filled Syringe (3, 5, 6 MIU/ml);
Injection in vail (1, 3, 5 MIU/ml);
Treat chronic hepatitis B, chronic hepatitis C, tumor and other viral infective disease with a broad spectrum of anti-tumor and immuno-regulating functions
njection is a purified sterile recombinant interferon product.
Indications: KINFERON® is indicated to treat the following diseases: Acute or chronic viral hepatitis (Type B, Type C, etc.), herpes zoster, condylomata acuminate, hairy cell leukemia, chronic myelogenous leukemia, multiple myeloma, non-Hodgkin’s lymphoma, malignant melanoma, renal cell carcinoma, laryngeal papillomatosis, Kaposi’s sarcoma, ovary carcinoma, basal cell carcinoma, surface bladder carcinoma, etc.
njection is a purified sterile recombinant interferon product.
Indications: KINFERON® is indicated to treat the following diseases: Acute or chronic viral hepatitis (Type B, Type C, etc.), herpes zoster, condylomata acuminate, hairy cell leukemia, chronic myelogenous leukemia, multiple myeloma, non-Hodgkin’s lymphoma, malignant melanoma, renal cell carcinoma, laryngeal papillomatosis, Kaposi’s sarcoma, ovary carcinoma, basal cell carcinoma, surface bladder carcinoma, etc.
